← Leaderboards

Jan C Buckner

Mayo Clinic Coll Of Medicine, Rochester

Google Scholar ↗PubMed ↗ORCID ↗

$13,181,861

Attributed

$13,181,861

Total exposure

12

Grants

5

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $11.3M · FY2005–23

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$142,760,423 · 14

By mechanism

U10$75,349,100 · 6

UG1$54,951,557 · 2

U24$8,554,852 · 1

P30$2,271,737 · 1

P50$1,630,849 · 2

M01$2,328 · 2

Top collaborators

Electra D. Paskett6 shared

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Alex A Adjei$13,436,633
Andre T Baron$411,337
James Newell Ingle$11,197,195
Richard M Weinshilboum$55,444,344
Christopher G Chute$29,045,184

Others in their field

Top investigators on “Research Personnel”

David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
Sonia M Thomas · Research Triangle Institute$700,865,642
Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
Tracy L Nolen · Research Triangle Institute$474,487,152
David R. Weir · University Of Michigan At Ann Arbor$364,053,504
Judith S. Currier · University Of California Los Angeles$284,675,012

Research focus

Research PersonnelClinical TrialsClinical ResearchCancer PatientQuality Of LifeResourcesTranslational ResearchProtocols DocumentationNorth Central Cancer Treatment GroupCommunity Clinical Oncology ProgramMemberBaseTranslational StudyProgramsCollectionPathologyNeuro-OncologyEnrollmentDatabasesCancer PreventionCancer TherapyMultidisciplinaryBiologicalCommunities

Grant awards (68)

Collaborations and NCORP Collective Management$406,615

UG1 · FY2023 · CA · contact PI

Alliance NCORP Research Base$7,197,176

UG1 · FY2019 · CA · contact PI

Alliance NCORP Research Base$7,362,635

UG1 · FY2018 · CA · contact PI

Alliance NCORP Research Base$11,328,914

UG1 · FY2017 · CA · contact PI

Alliance NCORP Research Base$8,075,549

UG1 · FY2016 · CA · contact PI

Alliance NCORP Research Base$10,950,397

UG1 · FY2015 · CA · contact PI

Clinical Research Core$140,833

P50 · FY2015 · CA · contact PI

Alliance NCORP Research Base$9,630,271

UG1 · FY2014 · CA · contact PI

North Central Cancer Treatment Group (NCCTG) Biospecimen Resource$712,057

U24 · FY2014 · CA · contact PI

Clinical Research Core$118,299

P50 · FY2014 · CA · contact PI

North Central Cancer Treatment Group$5,872,026

U10 · FY2013 · CA · contact PI

North Central Cancer Treatment Group (NCCTG) Biospecimen Resource$838,814

U24 · FY2013 · CA · contact PI

Clinical Research Core$148,331

P50 · FY2013 · CA · contact PI

North Central Cancer Treatment Group$5,558,123

U10 · FY2012 · CA · contact PI

North Central Cancer Treatment Group (NCCTG) Biospecimen Resource$892,355

U24 · FY2012 · CA · contact PI

Clinical Research Core$161,893

P50 · FY2012 · CA · contact PI

North Central Cancer Treatment Group$5,018,658

U10 · FY2011 · CA · contact PI

North Central Cancer Treatment Group$1,347,651

U10 · FY2011 · CA · contact PI

North Central Cancer Treatment Group (NCCTG) Biospecimen Resource$872,783

U24 · FY2011 · CA · contact PI

NCCTG Biospecimen Resource$19,572

U24 · FY2011 · CA · contact PI

North Central Cancer Treatment Group$5,882,621

U10 · FY2010 · CA · contact PI

NCCTG Biospecimen Resource$892,355

U24 · FY2010 · CA · contact PI

North Central Cancer Treatment Group$347,136

U10 · FY2010 · CA · contact PI

North Central Cancer Treatment Group$5,852,515

U10 · FY2009 · CA · contact PI

NCCTG Biospecimen Resource$892,355

U24 · FY2009 · CA · contact PI

North Central Cancer Treatment Group$797,973

U10 · FY2009 · CA · contact PI

North Central Cancer Treatment Group$225,000

U10 · FY2009 · CA · contact PI

North Central Cancer Treatment Group$5,842,715

U10 · FY2008 · CA · contact PI

NCCTG Biospecimen Resource$866,365

U24 · FY2008 · CA · contact PI

CORE--CLINICAL RESEARCH OFFICE$629,344

P30 · FY2008 · CA · contact PI

CORE--CLINICAL RESEARCH FACILITY$258,893

P50 · FY2008 · CA · contact PI

North Central Cancer Treatment Group$6,270,833

U10 · FY2007 · CA · contact PI

North Central Cancer Treatment Group$2,543,699

U10 · FY2007 · CA · contact PI

NCCTG Biospecimen Resource$857,786

U24 · FY2007 · CA · contact PI

CORE--CLINICAL RESEARCH OFFICE$621,180

P30 · FY2007 · CA · contact PI

North Central Cancer Treatment Group$300,000

U10 · FY2007 · CA · contact PI

CORE--CLINICAL RESEARCH FACILITY$284,042

P50 · FY2007 · CA · contact PI

North Central Cancer Treatment Group$222,000

U10 · FY2007 · CA · contact PI

NORTH CENTRAL CANCER TREATMENT GROUP$6,461,110

U10 · FY2006 · CA · contact PI

NCCTG Biospecimen Resource$857,674

U24 · FY2006 · CA · contact PI

CORE--CLINICAL RESEARCH OFFICE$336,070

P30 · FY2006 · CA · contact PI

CORE--CLINICAL RESEARCH FACILITY$165,178

P50 · FY2006 · CA · contact PI

NORTH CENTRAL CANCER TREATMENT GROUP$4,846,524

U10 · FY2005 · CA

NCCTG Biospecimen Resource$852,736

U24 · FY2005 · CA

CORE--CLINICAL RESEARCH OFFICE$326,646

P30 · FY2005 · CA

CORE--CLINICAL RESEARCH FACILITY$174,352

P50 · FY2005 · CA

PHASE 1B/II TRIAL OF CPT-11 AND RADIATION FOLLOWED BY CPT-11 AND BCNU$474

M01 · FY2005 · RR

NCCTG - Foreign Accrual$0

U10 · FY2005 · CA

NORTH CENTRAL CANCER TREATMENT GROUP$5,247,035

U10 · FY2004 · CA

CORE--CLINICAL RESEARCH OFFICE$358,497

P30 · FY2004 · CA

CORE--CLINICAL RESEARCH FACILITY$179,028

P50 · FY2004 · CA

Phase 1/II Trial of CPT-11/Radiation with CPT-11 &BCNU$1,854

M01 · FY2004 · RR

NCCTG FOREIGN ACCRUAL$0

U10 · FY2004 · CA

NORTH CENTRAL CANCER TREATMENT GROUP$5,742,095

U10 · FY2003 · CA

NORTH CENTRAL CANCER TREATMENT GROUP$706,898

U10 · FY2003 · CA

North Central Cancer Treatment Group$336,136

U10 · FY2003 · CA

NCCTG Foreign Accrual$0

U10 · FY2003 · CA

NORTH CENTRAL CANCER TREATMENT GROUP$5,504,843

U10 · FY2002 · CA

NORTH CENTRAL CANCER TREATMENT GROUP$108,029

U10 · FY2002 · CA

DATA MONITORING$78,870

U10 · FY2002 · CA

DATA MONITORING$78,870

U10 · FY2002 · CA

NEUROONCOLOGY$78,870

U10 · FY2002 · CA

NEUROONCOLOGY$78,870

U10 · FY2002 · CA

INTRAVENOUS CCI 799 GIVEN TO PATIENTS W/ ADVANCED SOLID TUMORS$0

M01 · FY2002 · RR

DATA MONITORING$0

U10 · FY2001 · CA

NEUROONCOLOGY$0

U10 · FY2001 · CA

INTRAVENOUS CCI 799 GIVEN TO PATIENTS W/ ADVANCED SOLID TUMORS$0

M01 · FY2001 · RR

INTRAVENOUS CCI 799 GIVEN TO PATIENTS W/ ADVANCED SOLID TUMORS$0

M01 · FY2000 · RR